Clinical Trial Update: Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating a combination of docetaxel, estramustine, and exisulind in patients with metastatic prostate cancer that progressed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)
• Estramustine (estramustine)
• Exisulind (exisulind)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED